Symposium (III)
Controversies and unmet needs for long-term benefit of HBV therapies
September 26, 2020（Saturday）13:40-15:20
Conference Room A, NTUH International Convention Center
Conference Room A, NTUH International Convention Center
* you can left or right swipe program.
| Time | Topic | Speaker | Moderator |
|---|---|---|---|
| Opening Remarks |
Rong-Nan Chien
Linkou Chang Gung Memorial Hospital
|
||
| Update of HBV practice guideline |
Chia-Yen Dai
Kaohsiung Medical University Chung-Ho Memorial Hospital
|
Rong-Nan Chien
Linkou Chang Gung Memorial Hospital
|
|
| Should we treat CHB patients earlier? |
Tai-Chung Tseng
National Taiwan University Hospital
|
Chun-Jen Liu
National Taiwan University Hospital
|
|
| Should we individually discontinue NUCs in CHB patients? |
Yi-Cheng Chen
Linkou Chang Gung Memorial Hospital
|
Han-Chieh Lin
Taipei Veterans General Hospital
|
|
| The risk of hepatocellular carcinoma among HBV patients outside current treatment criteria |
W. Ray Kim
Stanford University Medical Center, USA
|
Tsung-Hui Hu
Kaohsiung Chang Gung Memorial Hospital
|
|
| Discussion and closing remarks |
All
|
Jia-Horng Kao
National Taiwan University Hospital
|
|
* you can left or right swipe program.